Phase 2 study of RK-023 patients with androgenetic alopecia (male pattern baldness) -A study for safety and preliminary estimation of hair re-growth in male subjects with androgenetic alopecia treated for 13 weeks with RK-023
Phase 2
- Conditions
- Androgenetic alopecia (male pattern baldness)
- Registration Number
- JPRN-jRCT2080220997
- Lead Sponsor
- R-Tech Ueno, Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- Male
- Target Recruitment
- 48
Inclusion Criteria
Men aged between 20 and 44 years with an androgenetic alopecia rated as Takashima modified classification of Norwood-Hamiltonstage, IIv, IIIv and IV
Exclusion Criteria
Subjects with the complication that treatment is required
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method umber of cases with side-effects (Safety), change for anagen hair ratio (Efficacy)<br>Clinical valuation (Safety)<br>Phototrichogram (Efficacy)
- Secondary Outcome Measures
Name Time Method Global photograph of vertex (Efficacy)<br>Global photograph of vertex